| mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
| mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
Sorafenib |
FIMM |
pan-cancer |
AAC |
-0.03 |
0.9 |
| mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.006 |
0.9 |
| mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |